| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6062284 | Journal of Allergy and Clinical Immunology | 2016 | 12 Pages |
Abstract
The use of a LABA but not an LTRA as an “add-on controller” is associated with increased risk of asthma exacerbation in children carrying 1 or 2 AÂ alleles at rs1042713. Prospective genotype-stratified clinical trials are now required to explore the potential role of rs1042713 genotyping for personalized asthma therapy in children.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Steve MD, Ben PhD, Susanne PhD, Maria PhD, Anke H. PhD, Kaninika MD, Lauren MBBS, Somnath MD, Roger PhD, Colin PhD, Daniel PhD, Munir PhD, Esteban G. MD, MPH, Brian MD,